Groombridge, Wu, Baughman & Stone

Groombridge, Wu, Baughman & Stone have established an excellent patent litigation team in the pharma and biotech sectors. The team frequently act as lead counsel on multi-patent competitor disputes and Hatch-Waxman cases. The team have recently protected the liquid nanoparticle technology behind Pfizer’s COVID-19 vaccine for its client Acuitas Therapeutics. At the helm of the practice is Nicholas Groombridge, located in New York, who has an excellent reputation for litigating high-stakes patent disputes across a broad array of life sciences and technical areas. Groombridge co-leads the team with three other seasoned patent litigators. Jennifer Wu and Eric Alan Stone, both based in New York, excel in business-critical disputes related to pharmaceuticals, biotechnology and medical devices. The team’s leadership also includes Steven Baughman, based in Washington DC, who is recognised as an expert at the PTAB representing multinational corporations like Novo Nordisk and Apple. Megan Raymond, another key attorney in Washington DC, specializes in post-grant proceedings at the PTAB.